Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-20-118552
Filing Date
2020-10-27
Accepted
2020-10-27 16:11:51
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2033419-5_s1a.htm S-1/A 483597
2 EXHIBIT 4.10 tm2033419d5_ex4-10.htm EX-4.10 218211
3 EXHIBIT 4.11 tm2033419d5_ex4-11.htm EX-4.11 22594
4 GRAPHIC lg_titanpharma-4clr.jpg GRAPHIC 243683
  Complete submission text file 0001104659-20-118552.txt   1058390
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-249550 | Film No.: 201264262
SIC: 2836 Biological Products, (No Diagnostic Substances)